MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

monoclonal antibody

  • FDA Approves Absurd Drug to Delay Diabetes
    FDA Approves Absurd Drug to Delay Diabetes
    A monoclonal antibody injection has been approved for type 1 diabetes. It only costs about $200,000 and comes with a risk of serious side effects. STORY AT-A-GLANCE The U.S. Food ...
    February 13, 2023BY Joseph Mercola
  • FDA Approves Monoclonal Antibody to Treat COVID-19 for First Time
    FDA Approves Monoclonal Antibody to Treat COVID-19 for First Time
    The U.S. Food and Drug Administration (FDA) has, for the first time, approved a monoclonal antibody to treat COVID-19 ...
    December 21, 2022BY Mimi Nguyen Ly
  • Cancer Trial Using Monoclonal Antibody Finds Remission in Every Patient: Report
    Cancer Trial Using Monoclonal Antibody Finds Remission in Every Patient: Report
    A cancer trial has reportedly become the first in the world to completely remove the disease in every ...
    June 6, 2022BY Katabella Roberts
  • FDA Authorizes Emergency Use for Monoclonal Antibody Drug Amid $720 Million Deal
    FDA Authorizes Emergency Use for Monoclonal Antibody Drug Amid $720 Million Deal
    The Food and Drug Administration (FDA) on Friday announced it handed down an emergency use authorization for Eli ...
    February 11, 2022BY Jack Phillips
  • GSK-Vir Monoclonal Antibody Protects Against Omicron Subvariant, Companies Say
    GSK-Vir Monoclonal Antibody Protects Against Omicron Subvariant, Companies Say
    The monoclonal antibody treatment from GlaxoSmithKline (GSK) and Vir BioTechnology protects well against the Omicron subvariant that is ...
    February 10, 2022BY Zachary Stieber
  • FDA Restricts Use of 2 Monoclonal Antibody Treatments
    FDA Restricts Use of 2 Monoclonal Antibody Treatments
    The U.S. Food and Drug Administration (FDA) announced Jan. 24 it is restricting the use of two monoclonal ...
    January 25, 2022BY Mimi Nguyen Ly
  • ‘Some of Them Will Die’: Alabama Hit Hard by Monoclonal Antibody Rationing
    ‘Some of Them Will Die’: Alabama Hit Hard by Monoclonal Antibody Rationing
    The federal government's sudden rationing of monoclonal antibody treatments, which are keeping Americans who get COVID-19 out of ...
    September 18, 2021BY Zachary Stieber
TOP NEWS
  • Armed Person ‘Lunged’ at Ohio Democratic Governor Nominee at Ohio Fair, Campaign Says
    1hr By Joseph Lord
    Armed Person ‘Lunged’ at Ohio Democratic Governor Nominee at Ohio Fair, Campaign Says
  • US Embassy Issues Health Alert for Cuba After ‘Significant Increase in Diarrheal Illness’
    4hr By Jacki Thrapp
    US Embassy Issues Health Alert for Cuba After ‘Significant Increase in Diarrheal Illness’
  • At Least 5 Dead as Amazon Cargo Aircraft Overruns Runway at Miami Airport
    4hr By Jack Phillips
    At Least 5 Dead as Amazon Cargo Aircraft Overruns Runway at Miami Airport
  • Maximum SNAP Benefits to Increase in Most States on Oct. 1
    5hr By Tom Gantert
    Maximum SNAP Benefits to Increase in Most States on Oct. 1
  • Most US Workers Fear Obsolescence in AI Era, Experts Say Adaptation Goes Beyond Tech
    5hr By Mary Prenon
    Most US Workers Fear Obsolescence in AI Era, Experts Say Adaptation Goes Beyond Tech
  • Iran Nuclear Deal Might Be Delayed Until Regime Change in Tehran, Energy Secretary Says
    6hr By Jack Phillips
    Iran Nuclear Deal Might Be Delayed Until Regime Change in Tehran, Energy Secretary Says
  • AfD Wins Key German Regional Election
    7hr By Etienne Fauchaire
    AfD Wins Key German Regional Election
  • Trump Administration Petitions Supreme Court to Allow Mail Ballot Restrictions
    7hr By Jack Phillips
    Trump Administration Petitions Supreme Court to Allow Mail Ballot Restrictions
  • US Envoys Hope for New Round of Ukraine–Russia Peace Talks After Meeting With Putin, Zelenskyy
    8hr By Tom Gantert
    US Envoys Hope for New Round of Ukraine–Russia Peace Talks After Meeting With Putin, Zelenskyy
  • DHS Expands List of US-Born Children Ineligible for Birthright Citizenship
    11hr By Tom Gantert
    DHS Expands List of US-Born Children Ineligible for Birthright Citizenship
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top